Therefore, in this study we sought to define whether platelets, and more specifically, platelet-derived TGFβ1, mediate IPF disease progression using both clinical patient samples and an animal model of pulmonary fibrosis. The gene discussed is TGFB1; the disease is pulmonary fibrosis.